Ridgetech Inc. (RDGT) experienced a dramatic surge in premarket trading on Tuesday, with shares jumping 68.6% to $2.31 on the Nasdaq. The move came on exceptionally heavy volume of 32.27 million shares, despite the absence of any new company announcements. The surge follows a recent disclosure that a major shareholder, HRT Financial LP, sold a significant portion of its stake.
According to a Form 4 filing with the Securities and Exchange Commission, HRT Financial LP, a 10% owner of Ridgetech, sold 57,998 Class A shares at $1.601 apiece on June 16. After the sale, HRT still holds 61,753 shares. The filing does not provide a reason for the sale, which is typical for such insider transaction reports.
Ridgetech is a micro-cap stock with a market capitalization of approximately $1.23 million and fewer than 900,000 shares outstanding. This thin trading float makes the stock highly susceptible to price swings, especially during premarket and after-hours sessions when liquidity is lower. The stock closed Monday at $1.37, down 2.1%, before the premarket surge.
The company has undergone significant corporate actions recently. In April, Ridgetech announced a 1-for-150 reverse stock split, which reduced its share count from about 134.8 million to approximately 898,906 shares. The move was aimed at maintaining its listing on the Nasdaq Capital Market, where it trades under the ticker RDGT.
Ridgetech, headquartered in Hangzhou, China, operates as a wholesale distributor of pharmaceutical and healthcare products. Its business includes retail drugstores, an online pharmacy, drug wholesale, and herb farming, according to MarketWatch's company profile. In March, the company outlined a "dual-engine" growth strategy for 2026, focusing on supply-chain integration, its Allright digital platform, and wholesale distribution. Interim CEO and CFO Frank Zhao emphasized "strengthening foundations while advancing innovation" as key priorities.
While the premarket jump is notable, investors should be aware of the risks associated with extended-hours trading. The Nasdaq warns that such sessions often see increased volatility and reduced liquidity, meaning prices can move sharply on relatively small volumes. For a stock like Ridgetech, with its tiny market cap and recent reverse split, the risk is particularly acute.
The regular trading session on the Nasdaq, which opens at 9:30 a.m. ET, will be a critical test for Ridgetech. The influx of additional liquidity during regular hours could either confirm the premarket gains or reverse them quickly. As of now, there is no sector-wide catalyst driving the move, suggesting it may be a micro-cap phenomenon tied to the insider sale and low float.
Competitors such as PetMed Express and CVS Health are much larger and more liquid stocks, underscoring the unique risks of trading Ridgetech. Investors should conduct thorough due diligence and consider the high volatility before making any trading decisions.
